Skip to Content

Elepsia XR Approval History

FDA Approved: Yes (First approved December 20, 2018)
Brand name: Elepsia XR
Generic name: levetiracetam
Dosage form: Extended-Release Tablets
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Epilepsy

Elepsia XR (levetiracetam) is an extended-release formulation of the antiepileptic drug levetiracetam designed to reduce pill burden in patients receiving high doses for the treatment of partial onset seizures.

Development History and FDA Approval Process for Elepsia XR

DateArticle
Sep 25, 2015Approval Sun Pharma Advanced Research Company Ltd. Receives Complete Response Letter for Elepsia XR
Mar  4, 2015Approval Sun Pharma Announces FDA Approval of Elepsia XR (levetiracetam) Extended-Release Tablets

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide